News

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin-film freeze-drying

CURO Group Holdings Corp. (NYSE: CURO) (“CURO” or the “Company”), a market leader in providing credit to non-prime consumers, today announced that it has made two $10,000 donations to Black mental

Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae” or the “Company”) today announced the appointment of two new board members to the Company’s board of directors, effective February 18, 2021.

Joining

February 18, 2021. DONTNOD Entertainment, an independent French studio that creates and develops video games announces its publication agenda for 2020 consolidated results. These publications will

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Pataday^® Once Daily Relief Extra Strength (olopatadine hydrochloride

Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced the treatment of the first patient in the Phase I TENDU trial, representing the start of clinical evaluation for the Company’s

BOOSTHEAT (FR0011814938 / BOOST), a French energy efficiency manufacturer, shares its vision of the market and its positioning in 2021 after the roll-out of its “2022 Efficiency Plan” in 2020.

I

Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter and full year 2020 results, with fourth-quarter net earnings of $316 million ($0.55 diluted earnings per share). Fourth-quarter

Nutrien Ltd (TSX, NYSE: NTR) announced today its Board of Directors (“Board”) declared an increase to its quarterly dividend to US$0.46 per share, equating to an annualized dividend of US$1.84 per

AbCellera (NASDAQ: ABCL) will present at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:20 p.m. Pacific Time.

A live audio webcast may be accessed

Wolters Kluwer Health today announced that Tift Regional Medical Center, the flagship hospital of Southwell, a not-for-profit health system in South Central Georgia, has selected POC Advisor™ for

Blackline Safety Corp. (TSX.V: BLN), a global leader of gas detection and connected safety solutions, today announced that Enovert has joined Blackline Collective. Enovert is one of the United

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today

Ultimovacs ASA ("Ultimovacs", ticker ULTI), a pharmaceutical company developing novel immunotherapies against cancer, announces its fourth quarter 2021 results today. A presentation by the

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a cannabis retailer with operations across the U.S., today announced the execution of subscription agreements with

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a cannabis retailer with operations across the United States, today released its consolidated financial results for

KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today reported its fourth quarter and full year 2020 results, which have been posted to the Investor Relations section of KREF’s website at

Blackline Safety Corp. (TSX.V: BLN), a global connected worker technology leader, has acquired Wearable Technologies Ltd. (WTL), based in Leicester, in the United Kingdom, and operating under the

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced it will be

BIO-UV Group (Euronext Growth^® - FR001334549 - ALTUV), a specialist in water and surface treatment and disinfection systems, is pleased to announce the signature of a technological and commercial

Regulatory News:

NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

Regulatory News:

NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), ein Biotechnologieunternehmen mit Fokus auf der Verbesserung von Krebstherapien durch gezielte Einwirkung auf die

SOL Global Investments Corp. (“SOL Global” or the “Company”)(CSE:SOL) (OTCPK: SOLCF) (Frankfurt:9SB) announces that it transferred and divested an aggregate of 16,891,749 common shares (“Common

Medallia Inc. (NYSE: MDLA), the global leader in experience management, today announced that it will report financial results for the fourth quarter and fiscal year 2021 on Thursday, March 4, 2021

Tufin (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced financial results for the fourth quarter and the year ended December 31, 2020.